CN108201474A - Valvuloplasty ring - Google Patents
Valvuloplasty ring Download PDFInfo
- Publication number
- CN108201474A CN108201474A CN201611179674.8A CN201611179674A CN108201474A CN 108201474 A CN108201474 A CN 108201474A CN 201611179674 A CN201611179674 A CN 201611179674A CN 108201474 A CN108201474 A CN 108201474A
- Authority
- CN
- China
- Prior art keywords
- parylene
- coating
- layer
- valvuloplasty ring
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/02—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/10—Definition of the polymer structure
- C08G2261/11—Homopolymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域technical field
本发明涉及医疗器械技术领域,特别是涉及一种心脏瓣膜成形环,该瓣膜成形环的表面涂覆有既能降低炎症又抗血栓的涂层。The invention relates to the technical field of medical devices, in particular to a heart valve forming ring, the surface of which is coated with a coating capable of reducing inflammation and resisting thrombus.
背景技术Background technique
对于瓣膜关闭不全、返流,常见治疗方法是瓣膜修复成形术。为了保持长期的治疗效果,在瓣膜修复成形术后,外科医生往往会在患者的瓣环位置植入一个人工瓣膜成形环,以保证自体瓣环的良好塑形,同时防止瓣环进一步扩大,以维持治疗效果。For valvular insufficiency, regurgitation, the common treatment is valvuloplasty. In order to maintain the long-term therapeutic effect, after valvuloplasty, the surgeon often implants an artificial valvuloplasty ring at the position of the valve annulus to ensure the good shaping of the native valve annulus and prevent further expansion of the valve annulus in order to maintain the long-term therapeutic effect. maintain the therapeutic effect.
现有的人工瓣膜成形环主要有三层结构,最内层为金属或高分子材料支撑体,中间层为硅胶,最外层是聚酯涤纶布;其中涤纶布起到的作用是有助于组织内生,可固定人工瓣环并减少裂开的风险。The existing artificial annuloplasty ring mainly has a three-layer structure, the innermost layer is metal or polymer material support body, the middle layer is silica gel, and the outermost layer is polyester polyester cloth; the role of polyester cloth is to help tissue Ingrown to stabilize the prosthetic annulus and reduce the risk of dehiscence.
尽管聚酯涤纶布本身具有一定生物相容性,但是当聚酯纤维制成的生物医用材料植入人体后,在血液中长期浸泡,其血液相容性并不能完全满足要求,存在凝血形成血栓和产生较重炎症的风险,直接影响材料的使用寿命,危及患者的安全。目前,上述问题仍未得到彻底解决。Although polyester polyester cloth itself has a certain biocompatibility, when the biomedical material made of polyester fiber is implanted into the human body and soaked in the blood for a long time, its blood compatibility cannot fully meet the requirements, and there will be coagulation and thrombus formation. And the risk of severe inflammation will directly affect the service life of the material and endanger the safety of patients. At present, the above-mentioned problems have not been completely resolved.
发明内容Contents of the invention
基于此,有必要针对上述缺陷提供一种心脏瓣膜成形环。该成形环在涤纶布外层的外表面涂覆Parylene涂层,在降低炎症的同时又能抗血栓。Based on this, it is necessary to provide a heart valvuloplasty ring to address the above defects. The forming ring is coated with a Parylene coating on the outer surface of the polyester cloth outer layer, which is anti-thrombotic while reducing inflammation.
本发明提供一种心脏瓣膜成形环,包括金属管内层、包覆于所述金属管内层外表面的硅胶层中间层以及包覆于所述硅胶层中间层外表面的涤纶布外层;所述涤纶布外层的外表面涂覆有0.01~100μm厚的聚对二甲苯(Parylene)涂层。The present invention provides a heart valvuloplasty ring, which comprises an inner layer of a metal tube, an intermediate layer of a silica gel layer covering the outer surface of the inner layer of the metal tube, and an outer layer of polyester cloth covering the outer surface of the intermediate layer of the silica gel layer; The outer surface of the polyester cloth outer layer is coated with a 0.01-100 μm thick parylene (Parylene) coating.
在其中一个实施例中,所述聚对二甲苯为聚对二甲苯C或聚对二甲苯N。In one embodiment, the parylene is parylene C or parylene N.
在其中一个实施例中,所述聚对二甲苯涂层的厚度为0.1~50μm。In one embodiment, the parylene coating has a thickness of 0.1-50 μm.
在其中一个实施例中,当所述聚对二甲苯为聚对二甲苯C时,所述聚对二甲苯涂层的厚度为0.5~30μm。In one embodiment, when the parylene is parylene C, the thickness of the parylene coating is 0.5-30 μm.
在其中一个实施例中,当所述聚对二甲苯为聚对二甲苯C时,所述聚对二甲苯涂层的厚度为1~20μm。In one embodiment, when the parylene is parylene C, the thickness of the parylene coating is 1-20 μm.
在其中一个实施例中,当所述聚对二甲苯为聚对二甲苯N时,所述聚对二甲苯涂层的厚度为0.5~35μm。In one embodiment, when the parylene is parylene N, the thickness of the parylene coating is 0.5-35 μm.
在其中一个实施例中,当所述聚对二甲苯为聚对二甲苯N时,所述聚对二甲苯涂层的厚度为1~25μm。In one embodiment, when the parylene is parylene N, the thickness of the parylene coating is 1-25 μm.
在其中一个实施例中,所述聚对二甲苯涂层的厚度为1~10μm。In one embodiment, the parylene coating has a thickness of 1-10 μm.
在其中一个实施例中,所述金属管为镍钛切割管。In one embodiment, the metal tube is a nickel-titanium cut tube.
本发明采用与涤纶布结合作用力强、且自身生物相容性好的聚对二甲苯涂层材料,通过控制聚对二甲苯涂层的厚度,使得制备得到的具有聚二甲苯涂层的心脏瓣膜成形环在降低炎症反应的同时,又能够有效的抗血栓。The present invention adopts a parylene coating material with strong binding force with polyester cloth and good self-biocompatibility, and by controlling the thickness of the parylene coating, the prepared heart with the parylene coating The valvuloplasty ring can effectively antithrombotic while reducing the inflammatory response.
附图说明Description of drawings
图1为现有技术中心脏瓣膜成形环的结构示意图;Fig. 1 is the structural representation of heart annuloplasty ring in the prior art;
图2为实施例1的涂覆聚对二甲苯C涂层的心脏瓣膜成形环的结构示意图;Fig. 2 is the schematic structural view of the cardiac valvuloplasty ring coated with Parylene C coating in Example 1;
图3为将实施例3的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 3 is the histopathological result figure that the heart valvuloplasty ring of embodiment 3 is implanted into pig's inferior vena cava 7 days;
图4为将实施例4的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 4 is the histopathological result figure that the heart valvuloplasty ring of embodiment 4 is implanted in pig's inferior vena cava 7 days;
图5为将实施例5的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 5 is the histopathological result figure that the heart valvuloplasty ring of embodiment 5 is implanted in pig's inferior vena cava 7 days;
图6为将实施例10的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 6 is a histopathological result figure taken out after 7 days after implanting the heart valvuloplasty ring of Example 10 into the pig's inferior vena cava;
图7为将实施例11的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 7 is a histopathological result diagram taken out 7 days after the heart valvuloplasty ring of Example 11 was implanted into the pig's inferior vena cava;
图8为将实施例12的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 8 is a diagram of the histopathological results after implanting the heart valvuloplasty ring of Example 12 into the pig's inferior vena cava 7 days;
图9为将对比实施例1的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图;Fig. 9 is a diagram of the histopathological results after implanting the heart valvuloplasty ring of Comparative Example 1 into the pig's inferior vena cava 7 days;
图10为将对比实施例2的心脏瓣膜成形环植入猪的下腔静脉7天后取出的组织病理结果图。Fig. 10 is a graph showing histopathological results taken out 7 days after the heart valvuloplasty ring of Comparative Example 2 was implanted into the pig's inferior vena cava.
具体实施方式Detailed ways
为了对本发明的技术特征、目的和效果有更加清楚的理解,现对照附图详细说明本发明的具体实施方式。In order to have a clearer understanding of the technical features, purposes and effects of the present invention, the specific implementation manners of the present invention will now be described in detail with reference to the accompanying drawings.
除非另有定义,本文所使用的所有的技术和科学术语属于本发明的技术领域的技术人员通常理解的含义相同。本文在说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the technical field of the invention. The terms used herein in the specification are for the purpose of describing specific embodiments only, and are not intended to limit the present invention.
国内外常用的一种心脏瓣膜成形环的结构如图1所示,该瓣膜成形环由金属环、可缝合环缘和衬布构成。金属环的材料为Ti-6Al-4V,环缘由一层硅橡胶构成,其外表面覆盖聚酯衬布。The structure of a heart valvuloplasty ring commonly used at home and abroad is shown in Figure 1. The valvuloplasty ring is composed of a metal ring, a suturable ring and an interlining. The material of the metal ring is Ti-6Al-4V, the ring edge is made of a layer of silicone rubber, and its outer surface is covered with polyester interlining.
传统聚酯材料的表面改性方法,是在聚酯材料的表面构建单功能的仿生涂层,往往只具备抗血栓或促进内皮化或降低炎症的单一功能,很难在保证涂层与涤纶布结合力的同时实现多功能作用。对涤纶布表面涂覆涂层的过程中,既要保证涂层与涤纶布的结合力,又要保证瓣膜成形环在涂覆涂层后,能够降低炎症并实现抗血栓。The surface modification method of traditional polyester materials is to construct a single-function biomimetic coating on the surface of polyester materials, which often only has a single function of anti-thrombosis or promoting endothelialization or reducing inflammation. It is difficult to ensure that the coating and polyester cloth Combined with multi-function. In the process of coating the surface of the polyester cloth, it is necessary to ensure the bonding force between the coating and the polyester cloth, and to ensure that the valvuloplasty ring can reduce inflammation and achieve antithrombosis after coating the coating.
聚对二甲苯(Parylene)可分为聚对二甲苯C(Parylene C,一氯取代)、聚对二甲苯D(Parylene D,二氯取代)、聚对二甲苯N(Parylene N,无取代)和聚对二甲苯HT(ParyleneHT,氟化物),多采用化学气相沉积工艺(CVD)制备得到,整个制备工艺为在真空条件下的气态反应,因而可以获得非常均匀的涂层。Parylene的气相沉积过程一般分为三步:(1)于真空状态、120℃将固态原料升华成气态原料;(2)于680℃将步骤(1)的气态原料裂解为具有反应特性的活性单体;(3)于25℃将步骤(2)的活性单体沉积并聚合。活性单体首先弥漫在工件的表面,当活性单体吸附到工件的各处表面后,开始聚合和结晶,直接形成固体,通过沉积时间控制涂层的厚度,一般沉积速度约1μm/60min。Parylene和涤纶布均含有苯环结构,相互之间的范德华作用力较强,保证了Parylene涂层与涤纶布的连接强度。Parylene can be divided into Parylene C (Parylene C, one chlorine substitution), Parylene D (Parylene D, dichlorination substitution), Parylene N (Parylene N, unsubstituted) And parylene HT (ParyleneHT, fluoride), mostly prepared by chemical vapor deposition (CVD), the whole preparation process is a gaseous reaction under vacuum conditions, so a very uniform coating can be obtained. The gas phase deposition process of Parylene is generally divided into three steps: (1) sublimation of solid raw materials into gaseous raw materials at 120°C in a vacuum state; (2) cracking of gaseous raw materials in step (1) into active single (3) Deposit and polymerize the active monomer of step (2) at 25°C. The active monomer first diffuses on the surface of the workpiece. When the active monomer is adsorbed to the surface of the workpiece, it starts to polymerize and crystallize, and directly forms a solid. The thickness of the coating is controlled by the deposition time. The general deposition speed is about 1μm/60min. Both Parylene and polyester fabric contain benzene ring structure, and the van der Waals force between them is strong, which ensures the connection strength between Parylene coating and polyester fabric.
涂覆不均匀,譬如产生气泡、杂质或异形等情形,容易影响涂层与涤纶布的连接强度。上述过程中,没有液相的出现,克服了厚度的不均匀和涂层中常见的缺陷,涂层均匀涂覆,也保证了涂层与基体的连接强度。Uneven coating, such as bubbles, impurities or irregularities, will easily affect the connection strength between the coating and the polyester cloth. In the above process, there is no liquid phase, which overcomes the uneven thickness and common defects in the coating, and the coating is evenly coated, which also ensures the connection strength between the coating and the substrate.
Parylene C为Parylene N的一氯取代物,极性较强,与涤纶布的结合力较Parylene N大。当采用Parylene C涂覆涂层时,涂层过厚会使得涤纶布的表面硬化,因此,Parylene C的适用范围较Parylene N小些。Parylene C is a monochlorine substitute of Parylene N, which has stronger polarity and greater binding force with polyester cloth than Parylene N. When Parylene C is used to coat the coating, too thick coating will harden the surface of the polyester cloth. Therefore, the applicable range of Parylene C is smaller than that of Parylene N.
聚对二甲苯涂层的厚度为0.01~100μm,优选为0.1~50μm。涂层太薄,其与涤纶布的结合力较弱,涂层容易脱落;涂层过厚,容易使涤纶布硬化。将聚对二甲苯涂层的厚度控制在0.01~100μm,能够保证涂层的效果,使得涂层在降低炎症反应的同时,又能够起到抗血栓的作用。The thickness of the parylene coating is 0.01-100 μm, preferably 0.1-50 μm. If the coating is too thin, its binding force with the polyester cloth is weak, and the coating is easy to fall off; if the coating is too thick, it is easy to harden the polyester cloth. Controlling the thickness of the parylene coating at 0.01-100 μm can ensure the effect of the coating, so that the coating can play an antithrombotic effect while reducing inflammation.
实施例1Example 1
请参见图2,一种心脏瓣膜成形环,包括镍钛切割管内层1、包覆于镍钛切割管内层1外表面的带有缝合缘5的硅胶中间层2以及包覆于硅胶中间层2外表面的涤纶布外层3,涤纶布外层3的外表面均匀涂覆有0.01μm厚的Parylene C涂层4。Please refer to Fig. 2, a kind of heart valvuloplasty ring, comprises nickel-titanium cutting tube inner layer 1, is coated on the outer surface of nickel-titanium cutting tube inner layer 1 outer surface with the silicone intermediate layer 2 with suture edge 5 and is coated on the silicone intermediate layer 2 The polyester cloth outer layer 3 on the outer surface, the outer surface of the polyester cloth outer layer 3 is uniformly coated with a 0.01 μm thick Parylene C coating 4 .
Parylene C涂层4的制备方法包括如下步骤:(1)于真空状态、120℃将一氯取代的对二甲苯环二体的固态原料升华成气态原料;(2)于680℃将步骤(1)的气态原料裂解为具有反应特性的一氯取代单体双游离基;(3)于25℃将步骤(2)的单体双游离基沉积36s并聚合,得到Parylene C涂层4;其中涂层的厚度由沉积时间控制,一般沉积速度为1μm/60min。其反应如式一所示。The preparation method of Parylene C coating 4 comprises the steps: (1) in vacuum state, 120 DEG C, the solid raw material of the p-xylene ring dimer of monochlorine substitution is sublimated into gaseous raw material; (2) in 680 DEG C, step (1 ) gaseous raw material is cracked into a chlorine-substituted monomer double radical with reactive characteristics; (3) the monomer double radical of step (2) is deposited and polymerized at 25°C for 36s to obtain Parylene C coating 4; wherein the coating The thickness of the layer is controlled by the deposition time, and the general deposition rate is 1μm/60min. Its reaction is shown in formula 1.
实施例2Example 2
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有0.1μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 0.1 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为6min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 6 minutes.
实施例3Example 3
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有1μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 1 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为60min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 60 min.
实施例4Example 4
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有10μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 10 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为600min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 600 min.
实施例5Example 5
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有20μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 20 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为1200min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 1200 min.
实施例6Example 6
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有50μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 50 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为3000min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 3000 min.
实施例7Example 7
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有100μm厚的Parylene C涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 100 μm thick Parylene C coating.
Parylene C涂层的制备方法与实施例1的Parylene C涂层的制备方法类似,区别在于其沉积时间为6000min。The preparation method of the Parylene C coating is similar to the preparation method of the Parylene C coating in Example 1, except that the deposition time is 6000 min.
实施例8Example 8
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有0.01μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 0.01 μm thick Parylene N coating.
Parylene N涂层的制备方法包括如下步骤:(1)于真空状态、120℃将对二甲苯环二体的固态原料升华成气态原料;(2)于680℃将步骤(1)的气态原料裂解为具有反应特性的活性单体双游离基;(3)于25℃将步骤(2)的活性单体双游离基沉积36s并聚合,得到Parylene N涂层;其中涂层的厚度由沉积时间控制,一般沉积速度为1μm/60min。其反应如式二所示。The preparation method of the Parylene N coating comprises the following steps: (1) sublimating the solid raw material of the p-xylene ring dimer into a gaseous raw material at 120° C. in a vacuum state; (2) cracking the gaseous raw material in step (1) at 680° C. It is an active monomer double radical with reactive characteristics; (3) deposit the active monomer double radical of step (2) at 25°C for 36s and polymerize to obtain a Parylene N coating; wherein the thickness of the coating is controlled by the deposition time , the general deposition rate is 1μm/60min. Its reaction is shown in formula 2.
实施例9Example 9
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有0.1μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 0.1 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为6min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 6 minutes.
实施例10Example 10
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有1μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 1 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为60min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 60 min.
实施例11Example 11
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有10μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 10 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为600min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 600 min.
实施例12Example 12
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有25μm厚的Parylene N涂层。The heart valvuloplasty ring of this embodiment has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 25 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为1500min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 1500 min.
实施例13Example 13
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有50μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 50 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为3000min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 3000 min.
实施例14Example 14
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有100μm厚的Parylene N涂层。The heart valvuloplasty ring of this example has a similar structure to the heart valvuloplasty ring of Example 1, the difference being that the outer surface of the polyester cloth outer layer is evenly coated with a 100 μm thick Parylene N coating.
Parylene N涂层的制备方法与实施例8的Parylene N涂层的制备方法类似,区别在于其沉积时间为6000min。The preparation method of the Parylene N coating is similar to the preparation method of the Parylene N coating in Example 8, except that the deposition time is 6000 min.
对比实施例1Comparative Example 1
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面没有涂覆涂层。The heart valvuloplasty ring of this embodiment has a similar structure to the heart valvuloplasty ring of Embodiment 1, the difference is that the outer surface of the polyester cloth outer layer is not coated with a coating.
对比实施例2Comparative Example 2
本实施例的心脏瓣膜成形环与实施例1的心脏瓣膜成形环具有类似的结构,其区别在于,涤纶布外层的外表面均匀涂覆有25μm厚的PTFE(聚四氟乙烯,Teflon)涂层。The heart valvuloplasty ring of the present embodiment has a similar structure to the heart valvuloplasty ring of embodiment 1, and the difference is that the outer surface of the polyester cloth outer layer is evenly coated with 25 μm thick PTFE (polytetrafluoroethylene, Teflon) coating. Floor.
PTFE涂层的制备方法包括如下步骤:利用气相沉积法以PTFE粉末为蒸发材料,将PTFE原料先热裂解成自由基或激发态,最后在涤纶布上沉积聚合为PTFE涂层。The preparation method of the PTFE coating includes the following steps: using the vapor phase deposition method to use PTFE powder as an evaporation material, thermally cracking the PTFE raw material into free radicals or excited states, and finally depositing and polymerizing the PTFE coating on the polyester cloth.
效果实施例Effect example
分别将上述实施例3~5、10~12以及对比实施例1和2的心脏瓣膜成形环植入猪的下腔静脉中,7天后取出相应的植入组织,进行石蜡切片,HE染色(苏木精-伊红染色),于显微镜下观察组织的炎症和血栓化的程度,结果如图3-10所示。The heart valvuloplasty rings of the above-mentioned Examples 3-5, 10-12 and Comparative Examples 1 and 2 were respectively implanted in the inferior vena cava of pigs, and the corresponding implanted tissues were taken out after 7 days, paraffin sections were carried out, and HE staining (Su Xylin-eosin staining), the degree of tissue inflammation and thrombosis was observed under a microscope, and the results are shown in Figure 3-10.
从上述图中可以看出,植入无涂层的心脏瓣膜成形环的组织的炎症反应明显,血栓化程度较高;植入PTFE涂层的心脏瓣膜成形环的组织的炎症反应和血栓化程度相对前者均较轻;植入ParyleneC型和N型涂层的心脏瓣膜成形环的组织的炎症反应最轻,血栓化程度最低。It can be seen from the above figure that the inflammatory response and the degree of thrombosis of the tissue implanted with the uncoated annuloplasty ring are obvious; the inflammatory response and the degree of thrombosis of the tissue implanted with the PTFE-coated annuloplasty ring Compared with the former, they were mild; the tissues implanted with Parylene C-type and N-type coated cardiac valvuloplasty rings had the mildest inflammatory response and the lowest degree of thrombosis.
上面结合附图对本发明的实施例进行了描述,但是本发明并不局限于上述的具体实施方式,上述的具体实施方式仅仅是示意性的,而不是限制性的,本领域的普通技术人员在本发明的启示下,在不脱离本发明宗旨和权利要求所保护的范围情况下,还可做出很多形式,这些均属于本发明的保护之内。Embodiments of the present invention have been described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementations, and the above-mentioned specific implementations are only illustrative, rather than restrictive, and those of ordinary skill in the art will Under the enlightenment of the present invention, many forms can also be made without departing from the gist of the present invention and the protection scope of the claims, and these all belong to the protection of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611179674.8A CN108201474A (en) | 2016-12-19 | 2016-12-19 | Valvuloplasty ring |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611179674.8A CN108201474A (en) | 2016-12-19 | 2016-12-19 | Valvuloplasty ring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108201474A true CN108201474A (en) | 2018-06-26 |
Family
ID=62601922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611179674.8A Pending CN108201474A (en) | 2016-12-19 | 2016-12-19 | Valvuloplasty ring |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108201474A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113440311A (en) * | 2021-07-23 | 2021-09-28 | 上海欣吉特生物科技有限公司 | Annuloplasty ring |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1292668A (en) * | 1998-02-17 | 2001-04-25 | 托马斯·A·施泰因克 | Expandable stent |
| CN1792336A (en) * | 2005-12-23 | 2006-06-28 | 西安交通大学 | Stent used for cholangiojejunostomy |
| CN103841913A (en) * | 2011-04-08 | 2014-06-04 | 柯惠有限合伙公司 | Flexible Microwave Catheters for Natural or Artificial Lumens |
| CN103841899A (en) * | 2011-09-13 | 2014-06-04 | 艾博特心脏血管系统公司 | Grasper Pusher Mechanism for Tissue Juxtaposition Systems |
| CN103889475A (en) * | 2011-08-15 | 2014-06-25 | Meko激光材料加工公司 | Resorbable stents which contain a magnesium alloy |
| CN104010593A (en) * | 2013-07-29 | 2014-08-27 | 金仕生物科技(常熟)有限公司 | Heart Valve Prosthesis Forming Ring |
| CN104258473A (en) * | 2014-09-29 | 2015-01-07 | 上海交通大学 | Spinning-enhanced poly-p-xylene composite film and preparation method thereof |
| CN104582782A (en) * | 2012-08-20 | 2015-04-29 | 奥雷制药有限公司 | Process for manufacturing drug delivery formulations |
| CN104853696A (en) * | 2012-10-18 | 2015-08-19 | 洛马维斯塔医药股份有限公司 | Reinforced expandable medical device |
| CN105530885A (en) * | 2013-09-13 | 2016-04-27 | 波士顿科学国际有限公司 | Ablation balloon with vapor deposited cover layer |
-
2016
- 2016-12-19 CN CN201611179674.8A patent/CN108201474A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1292668A (en) * | 1998-02-17 | 2001-04-25 | 托马斯·A·施泰因克 | Expandable stent |
| CN1792336A (en) * | 2005-12-23 | 2006-06-28 | 西安交通大学 | Stent used for cholangiojejunostomy |
| CN103841913A (en) * | 2011-04-08 | 2014-06-04 | 柯惠有限合伙公司 | Flexible Microwave Catheters for Natural or Artificial Lumens |
| CN103889475A (en) * | 2011-08-15 | 2014-06-25 | Meko激光材料加工公司 | Resorbable stents which contain a magnesium alloy |
| CN103841899A (en) * | 2011-09-13 | 2014-06-04 | 艾博特心脏血管系统公司 | Grasper Pusher Mechanism for Tissue Juxtaposition Systems |
| CN104582782A (en) * | 2012-08-20 | 2015-04-29 | 奥雷制药有限公司 | Process for manufacturing drug delivery formulations |
| CN104853696A (en) * | 2012-10-18 | 2015-08-19 | 洛马维斯塔医药股份有限公司 | Reinforced expandable medical device |
| CN104010593A (en) * | 2013-07-29 | 2014-08-27 | 金仕生物科技(常熟)有限公司 | Heart Valve Prosthesis Forming Ring |
| CN105530885A (en) * | 2013-09-13 | 2016-04-27 | 波士顿科学国际有限公司 | Ablation balloon with vapor deposited cover layer |
| CN104258473A (en) * | 2014-09-29 | 2015-01-07 | 上海交通大学 | Spinning-enhanced poly-p-xylene composite film and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 对二甲苯环二体组: "聚对二甲苯的性能与应用", 《江苏化工.市场七日讯》 * |
| 昝丽娜: "聚对二甲苯的制备及其应用研究进展", 《化学推进剂与高分子材料》 * |
| 胡国贞等: "薄膜涂层材料――聚对二甲苯", 《成都教育学院学报》 * |
| 陈曦等: "C型聚对二甲苯狗动脉植入——血液相容性初步研究", 《中国生物医学工程学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113440311A (en) * | 2021-07-23 | 2021-09-28 | 上海欣吉特生物科技有限公司 | Annuloplasty ring |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2190491B1 (en) | Process for the manufacture of medical devices having sol-gel derived ceramic regions with molded submicron surface features | |
| US5207706A (en) | Method and means for gold-coating implantable intravascular devices | |
| US5464438A (en) | Gold coating means for limiting thromboses in implantable grafts | |
| JP6929787B2 (en) | Fiber-reinforced artificial heart valve with wavy fibers | |
| EP2175903B1 (en) | Drug eluting medical devices having porous layers | |
| US20120283828A1 (en) | Non-woven fabric for medical use and process for the preparation thereof | |
| JP2018202235A (en) | Improved prosthetic heart valve with leaflet shelving | |
| US20150073544A1 (en) | Superabsorbent coated stents for vascular reduction and for anchoring valve replacements | |
| JP2016501100A (en) | Geometric control of bending characteristics in artificial heart valve leaflets | |
| JP2008513118A (en) | Elastic radiopaque adhesive composite and prosthesis | |
| CN110152065B (en) | Biomimetic micro-nano laminated hydrophobic biological valve and preparation method thereof | |
| CN106756898A (en) | The preparation method of antibacterial hydrophobic ZnO nanorod | |
| CN101548916A (en) | A medical equipment carrying extracellular matrix and its production method | |
| WO2015161469A1 (en) | Artificial joint cup, magnetic control sputtering coating film device and preparation method thereof | |
| CN104224409A (en) | Artificial cotyla cup, magnetron sputter coating device and preparation method of artificial cotyla cup and magnetron sputter coating device | |
| JP2021506467A (en) | Charged implantable medical device and how to prepare it | |
| CN108201474A (en) | Valvuloplasty ring | |
| WO2021248260A1 (en) | Metal material, preparation method therefor and application thereof | |
| CN111803252B (en) | Stainless steel, preparation method thereof and drug eluting stent | |
| CN111315419A (en) | Synthetic prosthetic valve leaflet | |
| CN111840663B (en) | Medicine-carrying implantation medical apparatus and preparation method thereof | |
| US20230293774A1 (en) | Stent graft with elastomeric impermeable layer | |
| EP3965694B1 (en) | Valved conduit with expandable frame | |
| US20100178311A1 (en) | Implant and method for its manufacture | |
| CN101607097B (en) | Biological polypeptide medical device and manufacturing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180626 |
|
| RJ01 | Rejection of invention patent application after publication |